Overview


According to FutureWise analysis, the market for Arterial Stents is expected to grow at a CAGR of 10.70% over the forecast period of 2023-2031. 

Arterial stents are small, mesh-like metal or bioabsorbable tubes designed to be implanted within narrowed or blocked arteries. They serve a critical role in interventional cardiology and vascular surgery, aimed at restoring and maintaining proper blood flow in arteries affected by atherosclerosis or other conditions that lead to arterial narrowing.

The primary function of arterial stents is to act as scaffolding within the affected blood vessel. Once inserted, they provide structural support, preventing the artery from collapsing or re-narrowing after an intervention. This helps to maintain an open passage for blood to flow through, ensuring vital oxygen and nutrients reach the surrounding tissues and organs. There are two main types of arterial stents: bare-metal stents (BMS) and drug-eluting stents (DES). Bare-metal stents are typically made of stainless steel or other alloys and do not have a specialized coating. They serve as a mechanical scaffold to hold the artery open. In contrast, drug-eluting stents are coated with medications gradually released over time. These medications help to inhibit the growth of scar tissue within the stent, reducing the risk of restenosis (re-narrowing) of the treated artery.

FutureWise Market Research has published a report that provides an insightful analysis of Arterial Stents Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Arterial Stents Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization

  • Bio-Rad Laboratories, Inc. India Pvt.
  • NIPRO Medical Corporation
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Terumo Medical Corporation
  • Thermo Fisher Scientific, Inc.
  • Medtronic Plc.
  • Narang Medical Ltd.
  • Greiner Bio-Onc

(Note: The list of the major players will be updated with the latest market scenario and trends)

The notable prevalence of cardiovascular disorders, encompassing conditions like peripheral artery disease, coronary artery disease, and other arterial ailments, is a prominent catalyst for the arterial stents market. Stents are pivotal in reinstating proper blood flow within constricted or obstructed arteries. Given the worldwide aging demographic, the probability of experiencing arterial conditions is heightened. Older individuals are more susceptible to conditions like atherosclerosis, which can lead to the need for arterial stenting procedures. Continuous innovation in stent design and materials, such as drug-eluting and bioresorbable stents, has improved the efficacy and safety of arterial stenting procedures, driving the market growth. The preference for minimally invasive techniques in healthcare has led to a surge in arterial stenting procedures. Stenting offers a less invasive alternative to traditional open surgeries, resulting in quicker recovery times and reduced hospital stays, driving the market growth.

However, arterial stenting procedures can be expensive, particularly when considering the cost of the stent itself, hospital fees, and associated medical expenses. This can be a significant barrier, particularly in regions with limited healthcare resources. In some cases, alternative treatment options like medication, lifestyle changes, or other interventional procedures may be considered before resorting to arterial stenting. This can limit the immediate demand for stenting procedures.

By Type

  • Bare-Metal Stents
  • Drug-Eluting Stents
  • Bio absorbable Stents

By Mode of Delivery

  • Balloon-Expandable Stents
  • Self-Expanding Stents

By Material

  • Metallic Stents
    • Cobalt Chromium
    • Platinum Chromium
    • Nickel Titanium
    • Stainless Steel
  • Other Stents

By End User

  • Hospitals Pharmacies
  • Cardiac Centers
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, well-established reimbursement policies, and a strong focus on technological advancements. Additionally, a growing aging population contributes significantly to the demand for arterial stents in this region. Conversely, the Asia-Pacific region is poised for substantial expansion in the forecast period due to the rising awareness of cardiovascular health, and improvements in healthcare infrastructure are driving market growth. 

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on Arterial Stents Market By Type, By Mode of Delivery, By Material, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections, which are represented in the format of data sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors, which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Arterial Stents Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Material Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Arterial Stents Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Arterial Stents Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Material Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Material Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Arterial Stents Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bare-Metal Stents
        2. Drug-Eluting Stents
        3. Bio absorbable Stents

  • 8.   Global Arterial Stents Market, By Mode of Delivery Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Balloon-Expandable Stents
        2. Self-Expanding Stents

  • 9.   Global Arterial Stents Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metallic Stents
         1.1. Cobalt Chromium
         1.2. Platinum Chromium
         1.3. Nickel Titanium
         1.4. Stainless Steel
        2. Other Stents

  • 10.   Global Arterial Stents Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Cardiac Centers
        3. Ambulatory Surgical Centers

  • 11.   North America Arterial Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Arterial Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Arterial Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Arterial Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Arterial Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bio-Rad Laboratories, Inc. India Pvt.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. NIPRO Medical Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. QIAGEN
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. F. Hoffmann-La Roche Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Terumo Medical Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Thermo Fisher Scientific, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic Plc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Narang Medical Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Greiner Bio-Onc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients